You can reach Katie on Signal at palmer.01. Amid ongoing battles over alternate supplies of blockbuster weight loss drugs, Eli Lilly filed new lawsuits against four telehealth firms and their ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...

The overturning of the FDA’s lab-developed tests rule is just the tip of the iceberg. With the loss of Chevron deference, ...

Novo Nordisk has filed a citizen petition with the FDA to block the compounding of liraglutide, a key ingredient in its diabetes and obesity medications, by outsourcing facilities. The move ...

Houston Chronicle reporter Julian Gill discusses his recent investigation on Eli Lilly targeting a Houston-based pharmacy over copycat weight loss drugs. Trump has just crushed Ireland’s ...

April 23 (UPI) --Eli Lilly Wednesday ... versions of Lilly drugs to get around Food and Drug Administration rules. The suits filed Wednesday are the latest in an ongoing battle Lilly is waging ...

Powered by its popular GLP-1 weight loss drugs, Eli ... legal when the drugs were on the FDA's shortage list, from which tirzepatide was recently removed. There will likely be a major battle ...

Amid ongoing battles over alternate supplies of blockbuster weight loss drugs, Eli Lilly filed new lawsuits against four telehealth firms and their affiliates, but is using a new line of attack ...

A federal judge has sided with the FDA over a decision last year to remove two Eli Lilly drugs — the Zepbound weight loss medicine and the Mounjaro diabetes treatment — from a shortages list ...

Eli Lilly has ... which had been legal when the drugs were on the FDA's shortage list, from which tirzepatide was recently removed. There will likely be a major battle, however, to reduce the ...